Skip to main content
Top
Published in: Osteoporosis International 11/2015

01-11-2015 | Editorial

Bone histomorphometry in diabetes mellitus

Authors: C. A. Moreira, D. W. Dempster

Published in: Osteoporosis International | Issue 11/2015

Login to get access

Excerpt

Diabetes mellitus (DM) is a common disease with many complications; recently, one more complication has been associated with DM, an increased risk of fragility fractures [13]. Both type 1 and type 2 diabetes patients display an increase in bone fragility, which appears to be somewhat independent of bone mineral density (BMD) [4]. In fact, type 2 diabetes (T2D) patients have, in general, normal BMD while type 1 patients (T1D) have low BMD, which may contribute to fracture risk, but does not fully account for it [5, 6]. In this regard, a study analyzing bone material strength (BMS) using microindentation testing in vivo, demonstrated that postmenopausal women with T2D had lower BMS, and therefore compromised bone material properties, which were negatively correlated with glycated hemoglobin [7]. This suggests that the excess fracture risk in diabetes may be related to poor bone quality, raising questions regarding bone structure, material properties, and remodeling activity in these patients. In addition, poor glucose control and hypoglycemia besides other features related to the diabetic patient such as impaired vision and balance due to retinopathy and neuropathy increase fall and fracture risk. [8]. …
Literature
1.
go back to reference Jackuliak P, Payer J (2014) Osteoporosis, fractures, and diabetes. Int J Endocrinol :2–10 Jackuliak P, Payer J (2014) Osteoporosis, fractures, and diabetes. Int J Endocrinol :2–10
2.
go back to reference Liao CC, Lin CS, Shih CC, Yeh CC, Chang YC, Lee YW, Chen TL (2014) Increased risk of fracture and postfracture adverse events in patients with diabetes: two nationwide population-based retrospective cohort studies. Diabetes Care 37(8):2246–2252CrossRefPubMed Liao CC, Lin CS, Shih CC, Yeh CC, Chang YC, Lee YW, Chen TL (2014) Increased risk of fracture and postfracture adverse events in patients with diabetes: two nationwide population-based retrospective cohort studies. Diabetes Care 37(8):2246–2252CrossRefPubMed
3.
go back to reference Giangregorio LM, Leslie WD, Lix LM, Johansson H, Oden A, McCloskey E, Kanis JA (2012) FRAX underestimates fracture risk in patients with diabetes. J Bone Miner Res 27(2):301–308CrossRefPubMed Giangregorio LM, Leslie WD, Lix LM, Johansson H, Oden A, McCloskey E, Kanis JA (2012) FRAX underestimates fracture risk in patients with diabetes. J Bone Miner Res 27(2):301–308CrossRefPubMed
4.
go back to reference Vestergaard P (2007) Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes—a meta-analysis. Osteoporos Int 18(4):427–444CrossRefPubMed Vestergaard P (2007) Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes—a meta-analysis. Osteoporos Int 18(4):427–444CrossRefPubMed
5.
go back to reference Mastrandrea LD, Wactawski-Wende J, Donahue RP, Hovey KM, Clark A, Quattrin T (2008) Young women with type 1 diabetes have lower bone mineral density that persists over time. Diabetes Care 31:1729–1735PubMedCentralCrossRefPubMed Mastrandrea LD, Wactawski-Wende J, Donahue RP, Hovey KM, Clark A, Quattrin T (2008) Young women with type 1 diabetes have lower bone mineral density that persists over time. Diabetes Care 31:1729–1735PubMedCentralCrossRefPubMed
6.
go back to reference Strotmeyer ES, Cauley JA, Orchard TJ, Steenkiste AR, Dorman JS (2006) Middle-aged premenopausal women with type 1 diabetes have lower bone mineral density and calcaneal quantitative ultrasound than nondiabetic women. Diabetes Care 29:306–311CrossRefPubMed Strotmeyer ES, Cauley JA, Orchard TJ, Steenkiste AR, Dorman JS (2006) Middle-aged premenopausal women with type 1 diabetes have lower bone mineral density and calcaneal quantitative ultrasound than nondiabetic women. Diabetes Care 29:306–311CrossRefPubMed
7.
go back to reference Farr JN, Drake MT, Amin S, Melton LJ 3rd, McCready LK, Khosla S (2014) In vivo assessment of bone quality in postmenopausal women with type 2 diabetes. J Bone Miner Res 29(4):787–795PubMedCentralCrossRefPubMed Farr JN, Drake MT, Amin S, Melton LJ 3rd, McCready LK, Khosla S (2014) In vivo assessment of bone quality in postmenopausal women with type 2 diabetes. J Bone Miner Res 29(4):787–795PubMedCentralCrossRefPubMed
8.
go back to reference de Vittinghoff E, Sellmeyer SAV, Feingold KR, de Rekeneire N et al (2008) Diabetes-related complications, glycemic control, and falls in older adults. Diabetes Care 31(5):391–396PubMedCentralPubMed de Vittinghoff E, Sellmeyer SAV, Feingold KR, de Rekeneire N et al (2008) Diabetes-related complications, glycemic control, and falls in older adults. Diabetes Care 31(5):391–396PubMedCentralPubMed
9.
11.
go back to reference Klein, Frost, Sedlin (1964) A pilot study of lamellar bone physiology in diabetes mellitus. Henri Ford Hosp Med Bull 12:55–62 Klein, Frost, Sedlin (1964) A pilot study of lamellar bone physiology in diabetes mellitus. Henri Ford Hosp Med Bull 12:55–62
12.
go back to reference Leite Duarte ME, da Silva RD (1996) Histomorphometric analysis of the bone tissue in patients with non-insulin-dependent diabetes. Rev Hosp Clin Fac Med Sao Paulo 51(1):7–11PubMed Leite Duarte ME, da Silva RD (1996) Histomorphometric analysis of the bone tissue in patients with non-insulin-dependent diabetes. Rev Hosp Clin Fac Med Sao Paulo 51(1):7–11PubMed
13.
go back to reference Krakauer JC, McKenna MJ, Buderer NF, Rao DS, Whitehouse FW, Parfitt AM (1995) Bone loss and bone turnover in diabetes. Diabetes 44(7):775–782CrossRefPubMed Krakauer JC, McKenna MJ, Buderer NF, Rao DS, Whitehouse FW, Parfitt AM (1995) Bone loss and bone turnover in diabetes. Diabetes 44(7):775–782CrossRefPubMed
14.
go back to reference Manavalan JS, Cremers S, Dempster DW, Zhou H, Dworakowski E, Kode A, Kousteni S, Rubin MR (2012) Circulating osteogenic precursor cells in type 2 diabetes mellitus. J Clin Endocrinol Metab 97(9):3240–3250PubMedCentralCrossRefPubMed Manavalan JS, Cremers S, Dempster DW, Zhou H, Dworakowski E, Kode A, Kousteni S, Rubin MR (2012) Circulating osteogenic precursor cells in type 2 diabetes mellitus. J Clin Endocrinol Metab 97(9):3240–3250PubMedCentralCrossRefPubMed
15.
go back to reference Yamamoto M, Yamaguchi T, Nawata K, Yamauchi M, Sugimoto T (2012) Decreased PTH levels accompanied by low bone formation are associated with vertebral fractures in postmenopausal women with type 2 diabetes. J Clin Endocrinol Metab 97(4):1277–1284CrossRefPubMed Yamamoto M, Yamaguchi T, Nawata K, Yamauchi M, Sugimoto T (2012) Decreased PTH levels accompanied by low bone formation are associated with vertebral fractures in postmenopausal women with type 2 diabetes. J Clin Endocrinol Metab 97(4):1277–1284CrossRefPubMed
16.
go back to reference Garcia-Martin A, Rozas-Moreno P, Reyes-García R, Morales-Santana S, García-Fontana B, García-Salcedo JA, Muñoz-Torres M (2012) Circulating levels of sclerostin are increased in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab 97:234–241CrossRefPubMed Garcia-Martin A, Rozas-Moreno P, Reyes-García R, Morales-Santana S, García-Fontana B, García-Salcedo JA, Muñoz-Torres M (2012) Circulating levels of sclerostin are increased in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab 97:234–241CrossRefPubMed
17.
go back to reference Gennari L, Merlotti D, Valenti R, Ceccarelli E, Ruvio M, Pietrini MG, Capodarca C, Franci MB, Campagna MS, Calabrò A, Cataldo D, Stolakis K, Dotta F, Nuti R (2012) Circulating sclerostin levels and bone turnover in type 1 and type 2 diabetes. J Clin Endocrinol Metab 97:1737–1744CrossRefPubMed Gennari L, Merlotti D, Valenti R, Ceccarelli E, Ruvio M, Pietrini MG, Capodarca C, Franci MB, Campagna MS, Calabrò A, Cataldo D, Stolakis K, Dotta F, Nuti R (2012) Circulating sclerostin levels and bone turnover in type 1 and type 2 diabetes. J Clin Endocrinol Metab 97:1737–1744CrossRefPubMed
18.
go back to reference Gaudio A, Privitera F, Battaglia K, Torrisi V, Sidoti MH, Pulvirenti I, Canzonieri E, Tringali G, Fiore CE (2012) Sclerostin levels associated with inhibition of the Wnt/β-catenin signaling and reduced bone turnover in type 2 diabetes mellitus. J Clin Endocrinol Metab 97(10):3744–3750CrossRefPubMed Gaudio A, Privitera F, Battaglia K, Torrisi V, Sidoti MH, Pulvirenti I, Canzonieri E, Tringali G, Fiore CE (2012) Sclerostin levels associated with inhibition of the Wnt/β-catenin signaling and reduced bone turnover in type 2 diabetes mellitus. J Clin Endocrinol Metab 97(10):3744–3750CrossRefPubMed
19.
go back to reference Ardawi MS, Akhbar DH, Alshaikh A, Ahmed MM, Qari MH, Rouzi AA, Ali AY, Abdulrafee AA, Saeda MY (2013) Increased serum sclerostin and decreased serum IGF-1 are associated with vertebral fractures among postmenopausal women with type-2 diabetes. Bone 56:355–362CrossRefPubMed Ardawi MS, Akhbar DH, Alshaikh A, Ahmed MM, Qari MH, Rouzi AA, Ali AY, Abdulrafee AA, Saeda MY (2013) Increased serum sclerostin and decreased serum IGF-1 are associated with vertebral fractures among postmenopausal women with type-2 diabetes. Bone 56:355–362CrossRefPubMed
20.
go back to reference Schwartz AV, Garnero P, Hillier TA, Sellmeyer DE, Strotmeyer ES, Feingold KR, Resnick HE, Tylavsky FA, Black DM, Cummings SR, Harris TB, Bauer DC (2009) Pentosidine and increased fracture risk in older adults with type 2 diabetes. J Clin Endocrinol Metab 94(7):2380–2386PubMedCentralCrossRefPubMed Schwartz AV, Garnero P, Hillier TA, Sellmeyer DE, Strotmeyer ES, Feingold KR, Resnick HE, Tylavsky FA, Black DM, Cummings SR, Harris TB, Bauer DC (2009) Pentosidine and increased fracture risk in older adults with type 2 diabetes. J Clin Endocrinol Metab 94(7):2380–2386PubMedCentralCrossRefPubMed
21.
go back to reference Saito M, Kida Y, Kato S, Marumo K (2014) Diabetes, collagen, and bone quality. Curr Osteoporos Rep 12:181–188CrossRefPubMed Saito M, Kida Y, Kato S, Marumo K (2014) Diabetes, collagen, and bone quality. Curr Osteoporos Rep 12:181–188CrossRefPubMed
Metadata
Title
Bone histomorphometry in diabetes mellitus
Authors
C. A. Moreira
D. W. Dempster
Publication date
01-11-2015
Publisher
Springer London
Published in
Osteoporosis International / Issue 11/2015
Print ISSN: 0937-941X
Electronic ISSN: 1433-2965
DOI
https://doi.org/10.1007/s00198-015-3258-z

Other articles of this Issue 11/2015

Osteoporosis International 11/2015 Go to the issue